Accent Therapeutics

Lexington, United States

Accent Therapeutics is a biopharmaceutical company.

$75.0M raised

Jan 2024

Series C

Biotechnology Medical Pharmaceutical Therapeutics

Top Investors

AbbVieBristol-Myers SquibbEcoR1 CapitalAtlas VentureGoogle Ventures

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Accent Therapeutics

How much funding has Accent Therapeutics raised?

Accent Therapeutics has raised $75.0M in total funding. The most recent round was Series C. The last funding was announced in January 2024.

Who are Accent Therapeutics's investors?

Accent Therapeutics's investors include AbbVie, Bristol-Myers Squibb, EcoR1 Capital, Atlas Venture, Google Ventures.

Where is Accent Therapeutics headquartered?

Accent Therapeutics is headquartered in Lexington, United States.

What does Accent Therapeutics do?

Accent Therapeutics is a biopharmaceutical company.

What stage is Accent Therapeutics at?

Accent Therapeutics is at the Series C stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated January 23, 2024.

MLA

"Accent Therapeutics — Funding & Investors." VCBacked, January 23, 2024, https://www.vcbacked.co/company/accent-therapeutics. Accessed June 3, 2026.

APA

VCBacked. (2024). Accent Therapeutics — Funding & Investors. Retrieved June 3, 2026, from https://www.vcbacked.co/company/accent-therapeutics

Wikipedia (cite web)

{{cite web |title=Accent Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/accent-therapeutics |website=VCBacked |access-date=June 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated January 23, 2024.

Similar Companies in Biotechnology